Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data.
Blood Adv
; 8(7): 1683-1686, 2024 Apr 09.
Article
in En
| MEDLINE
| ID: mdl-38231018
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Red-Cell Aplasia, Pure
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2024
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United States